ArticleHaematologica2022

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.

Ohad Benjamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.